Infection with SARS-CoV-2 causing COVID-19 in pregnancy is known to confer risks to both
the pregnant patient and fetus. A review of the current literature demonstrates that pregnant …

Purpose Pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection have a higher risk of hospitalization, admission to intensive care unit (ICU) …

Importance Existing reports of pregnant patients with COVID-19 disease who require
extracorporeal membrane oxygenation (ECMO) are limited, with variable outcomes noted for …

In the United States, 131,512 pregnant and peripartum women have been affected by
coronavirus disease (COVID-19), with 200 associated deaths (0.15%)(1). The hormonal …

Historically, pregnant women have been excluded from the majority of drug and vaccine
trials, a practice that has been criticized widely by the scientific community1–3. As a result …

Information related to coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in pregnant patients is limited and …

Pregnant and postpartum women rarely need the involvement of intensivists in their care.
When they do, it is crucial for their critical care physicians to be prepared to provide the best …

Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), and lung involvement is common. Patients with …

Objective: Extracorporeal membrane oxygenation (ECMO) is an intervention used for
patients with acute respiratory distress syndrome (ARDS) from COVID-19 who have failed …

Background Available data identify pregnancy as a strong determinant of a severe course of
COVID-19 with increased mortality. Extracorporeal membrane oxygenation (ECMO) remains …